IPO: Innova Captab may be a good buy after a post-listing re

The promoters Manoj Kumar Lohariwala and his brother Vinay Kumar Lohariwala are diluting their stakes from 67% to 52%. Of the issue proceeds, ₹168 crore would be used toward debt repayment and ₹72 crore for working capital requirements.

Related Keywords

Afghanistan , India , Kenya , Sri Lanka , Haryana , Vinay Kumar Lohariwala , Manoj Kumar Lohariwala , Sharon Bio , Intelligence Group , Harun Health Care , Innova Captab , Sharon Bio Medicine , Growth Prospects , Adding Sharon , Windlas Biotech , Ipo , Promoters , Debt , Working Capital , Markets ,